IPG Photonics (IPGP) Q1 Earnings Lag, Revenues Top Estimates

SNPS CSLT IPGP

IPG Photonics Corporation (IPGP - Free Report) reported first-quarter 2019 adjusted earnings of $1.02 per share, lagging the Zacks Consensus Estimate by a couple of cents. Further, the bottom line decreased 47% from the year-ago figure.

Revenues of $315 million surpassed the Zacks Consensus Estimate of $304.5 million. However, the figure declined 12% from the year-ago quarter.

Uncertainty in macroeconomic environment and geopolitical factors reduced demand in China and Europe, which impacted first-quarter revenues. However, Genesis acquisition contributed $24 million in total revenues during the reported quarter.

Revenues by Application

Materials processing (95.6% of total revenues) declined 11% year over year to $301.1 million, owing to weakness in 3D printing and metal cutting applications.

Further, revenues from other markets (4.4%) fell 32% year over year to reach almost $14 million. However, management is banking on sequential order growth witnessed from government and communications applications.

 

Revenues by Geography

Sales in United States and other North America (representing 20.6% of total sales) grew 65.4% year over year to $64.8 million.

However, sales in Eastern Europe/CIS (22%) decreased 16.6% from the year-ago quarter to $69.2 million. Moreover, sales in Germany (5.9%) plummeted 44% from the year-ago quarter to $18.6 million.

Revenues from China (36.3%) declined 24% to $114 million. Sales in Japan (5%) declined 20% from the year-ago quarter to $15.6 million.

Sales in other Asia and Australia, and rest of the world (approximately 10.2%) collectively declined almost 7% year over year to $32.4 million.

Revenues by Product Group

Sales of high-power CW lasers (56.8% of total revenues) declined 22% from the year-ago quarter to $179 million, primarily owing to weaker-than-expected demand in China and Europe, lower sales of lasers for cutting and additive manufacturing. However, management noted that demand for 10 kilowatt and 6 kilowatt ultra-high power CW lasers gained momentum.

Medium-power CW laser sales (5%) slumped 38.6% year over year, on account of weakness in additive manufacturing and cutting. Further, pulsed lasers sales (10%) of $31.4 million declined 17.8% year over year. QCW lasers sales (4.5%) fell 12.6% year over year to $14.2 million.

 

However, system sales (10.4%) of $32.6 million, increased significantly from year-ago figure of $9.5 million, primarily due to growth in materials processing, micro systems and Genesis acquisition.

Other revenues (13.4%) which include amplifiers, accessories, service, parts, among others came in at $42.2 million, up 5.6% year over year.

Margins in Detail

IPG Photonics reported gross margin of 47.3%, contracting 920 bps on a year-over-year basis. This can be attributed to higher manufacturing cost and lower revenue base.

As a percentage of revenues, operating expenses expanded 830 bps year over year to 25.6%, primarily due to higher investments in sales, engineering and administrative expenses. Consequently, operating margin contracted from 39.2% reported in the year-ago quarter to 21.7%.

Balance Sheet & Cash Flow

IPG Photonics ended the first quarter with $1.03 billion in cash & cash equivalents and short-term investments as compared with $1.04 billion reported in the previous quarter. Total debt (including current portion) came in at $44.5 million, down from $45.4 million in the previous quarter.

The company generated $45.6 million in cash flow from operations down from the previous quarter’s figure of $113 million.

Guidance

For the second quarter, IPG Photonics expects sales in the range of $340-$370 million. The Zacks Consensus Estimate for revenues is pegged at $349.6 million.

Earnings are projected in the range of 1.25-$1.55 per share. The Zacks Consensus Estimate for earnings is pegged at $1.54 per share.

Zacks Rank and Stocks to Consider

IPG Photonics carries a Zacks Rank #5 (Strong Sell).

A few better-ranked stocks in the broader technology sector are Castlight Health, Inc. (CSLT - Free Report) , Avid Technology, Inc. and Synopsys, Inc. (SNPS - Free Report) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Long-term earnings growth rate for Castlight, Avid Technology and Synopsys is pegged at 22.5%, 10% and 10%, respectively.

Is Your Investment Advisor Fumbling Your Financial Future?

See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”

Click to get it free >>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>